Your search for

21 results were returned

  1. Legal news
    08 May 2019
    Manufacturing and stockpiling waiver set to limit rights of holders of SPCs for medicines
    www.twobirds.com/en/news/articles/2019/global/manufacturing-and-stockpiling-waiver-set-to-limit-rights-of-holders-of-spcs-for-medicines

    On 17 April 2019, the European Parliament approved, by a large majority, an amendment of the Regulation on Supplementary Protection Certificates ("SPCs").

  2. Legal news
    07 May 2020
    Getting to know our newly appointed IP Partners
    www.twobirds.com/en/news/articles/2020/global/getting-to-know-our-newly-appointed-ip-partners

    Our international IP team are thrilled to announce the promotion of 3 new partners today. These promotions reflect our ongoing commitment to ensure the diversity of our team develops to reflect the rich pool of talent ...

  3. Legal news
    30 September 2019
    Bird & Bird secures win in preliminary injunction patent case before the Düsseldorf Courts
    www.twobirds.com/en/news/articles/2019/germany/bird-and-bird-secures-win-in-preliminary-injunction-patent-case-before-the-dusseldorf-courts

    On September 26, 2019, the Higher Regional Court of Düsseldorf confirmed on appeal that Teva Pharmaceutical Industries Ltd. (“Teva”) – one of Bird & Bird’s key clients – is entitled to a preliminary injunction against ...

  4. Legal news
    04 September 2019
    Patents: meaning of enablement in anticipation by prior art
    www.twobirds.com/en/news/articles/2019/global/patents-meaning-of-enablement-in-anticipation-by-prior-art

    The Patents Court has considered enablement in relation to anticipation of a claimed monoclonal antibody invention by prior art, and held the patent was invalid for lack of novelty; it was also obvious for lack of ...

  5. Legal news
    22 March 2021
    “Patent linkage” in Italy: only patents/SPCs on the active ingredient per se are relevant for the purpose of reimbursement of generic medicinal products
    www.twobirds.com/en/news/articles/2021/italy/patent-linkage-in-italy

    By resolution dated February 10, 2021 the Italian Medicines Agency (AIFA) clarified the criteria for generic medicinal products to be inserted in the Substitution List (“Lista di Trasparenza”).

  6. Legal news
    16 April 2021
    Neurim vs Mylan – Victory from the jaws of defeat
    www.twobirds.com/en/news/articles/2021/uk/neurim-vs-mylan--victory-from-the-jaws-of-defeat

    Will Smith discusses the unusual decision of a judge to vary his order made after trial where a patent upheld by him was revoked by the European Patent Office almost immediately after the order was made